Integrated Gut Microbiota, Metabolomics, and Network Pharmacology to Investigate the Anti-Alzheimer’s Mechanism of Tripterygium Glycoside
TG may serve as a potential therapeutic drug for preventing AD via the microbiota-gut-brain axis.
Authors
- Luobu Gesang (ORCID: https://orcid.org/0009-0008-3269-3362)
- Yongcang Zhang (ORCID: https://orcid.org/0000-0002-7626-661X)
- Niannian Wang (ORCID: https://orcid.org/0000-0003-4879-6936)
- Tao Wang (ORCID: https://orcid.org/0000-0002-5440-3732)
- Lan Liu
- Quxi Silang
Institutions
- Tibet University (CN)
- Changsha Medical University (CN)
- Tibet Autonomous Region People's Hospital (CN)
- Tibetan Traditional Medical College (CN)
Publication Details
- Journal
- Neuropsychiatric Disease and Treatment
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/ndt.s537129
- Primary Topic
- Natural Compounds in Disease Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00